Document Detail


Oral sumatriptan-associated transmural myocardial infarction.
MedLine Citation:
PMID:  8848207     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 43-year-old healthy man developed transmural myocardial infarction shortly after ingesting sumatriptan succinate 100 mg for migraine. Coronary arteriography revealed only minor irregularities in the left anterior descending artery. Oral sumatriptan should be used with caution in any patient with vascular risk factors and avoided in those with coronary artery disease or vasospasm.
Authors:
P O'Connor; P Gladstone
Related Documents :
24373377 - Value of speckle-tracking echocardiography and mri-based feature tracking analysis in a...
23993027 - Weaning of extracorporeal membrane oxygenation using continuous hemodynamic transesopha...
23160517 - Noninvasive image derived heart input function for cmrglc measurements in small animal ...
22140597 - Reference values for echocardiographic parameters and indexes of left ventricular funct...
19081327 - Orthodromic incessant atrioventricular reciprocating tachycardia in a dog.
20174637 - Improved energy supply regulation in chronic hypoxic mouse counteracts hypoxia-induced ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Neurology     Volume:  45     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  1995 Dec 
Date Detail:
Created Date:  1996-10-22     Completed Date:  1996-10-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2274-6     Citation Subset:  AIM; IM    
Affiliation:
Division of Neurology, St. Michael's Hospital, Toronto, ON, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Coronary Angiography
Electrocardiography
Humans
Male
Myocardial Infarction / chemically induced*,  physiopathology
Sumatriptan / adverse effects*
Chemical
Reg. No./Substance:
103628-46-2/Sumatriptan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia.
Next Document:  Focal suppression-burst on electrocorticography after temporal lobectomy.